These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17228462)

  • 1. Complications and side effects. Alberta clinic saves lives but faces new challenges.
    TreatmentUpdate; 2005 Mar; 17(2):1-3. PubMed ID: 17228462
    [No Abstract]   [Full Text] [Related]  

  • 2. How infrequent are opportunistic diseases and immune reconstitution syndromes among HIV-infected individuals who have favorable CD4+ cell count responses to antiretroviral therapy?
    Phillips P
    Clin Infect Dis; 2005 May; 40(9):1379-80; author reply 1380-1. PubMed ID: 15825049
    [No Abstract]   [Full Text] [Related]  

  • 3. Current status of HIV infection: a review for non-HIV-treating physicians.
    Knoll B; Lassmann B; Temesgen Z
    Int J Dermatol; 2007 Dec; 46(12):1219-28. PubMed ID: 18173512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution in several forms.
    Ball SC
    AIDS Read; 2005 Jan; 15(1):17-20. PubMed ID: 15685730
    [No Abstract]   [Full Text] [Related]  

  • 6. The house is burning: an HIV clinician's view after 20 years.
    Follansbee S
    Focus; 2001 Aug; 16(9):1-5. PubMed ID: 11692445
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus disease in HIV infection: twenty years of a regional population's experience.
    Kim S; Snider JJ; Gill MJ
    Clin Infect Dis; 2006 Jun; 42(12):1808-9. PubMed ID: 16705594
    [No Abstract]   [Full Text] [Related]  

  • 9. What do HIV-infected patients become after an opportunistic infection?
    Malafronte B; Perbost I; Pradier C; Bentz L; Dunais B; Dellamonica P
    AIDS; 2006 Jan; 20(2):309-11. PubMed ID: 16511436
    [No Abstract]   [Full Text] [Related]  

  • 10. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience.
    Loubiere S; el Filal KM; Sodqi M; Loundou A; Luchini S; Cleary S; Moatti JP; Himmich H
    Antivir Ther; 2008; 13(2):241-51. PubMed ID: 18505175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late presentation of HIV-infected individuals.
    Battegay M; Fluckiger U; Hirschel B; Furrer H
    Antivir Ther; 2007; 12(6):841-51. PubMed ID: 17926639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 14. Another year ... Another top 10 list.
    Zuniga JM
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(6):275-8. PubMed ID: 19164136
    [No Abstract]   [Full Text] [Related]  

  • 15. New antiretroviral treatment guidelines from the IAS-USA panel.
    Labarga P; Blanco F
    AIDS Rev; 2012; 14(4):290. PubMed ID: 23390673
    [No Abstract]   [Full Text] [Related]  

  • 16. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 17. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
    Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
    AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to highly active antiretroviral therapy among severely immuno-compromised HIV-infected patients in Cambodia.
    Madec Y; Laureillard D; Pinoges L; Fernandez M; Prak N; Ngeth C; Moeung S; Song S; Balkan S; Ferradini L; Quillet C; Fontanet A
    AIDS; 2007 Jan; 21(3):351-9. PubMed ID: 17255742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy 2002.
    Zambrano CH
    Posit Aware; 2002; 13(1):27. PubMed ID: 12216526
    [No Abstract]   [Full Text] [Related]  

  • 20. When to start antiretroviral therapy: a swinging pendulum?
    Gallant JE
    Top HIV Med; 2008; 16(2):82-8. PubMed ID: 18591715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.